B2Gold and Vertex Pharmaceuticals stand out as strong buys, driven by robust fundamentals, sector leadership, and clear ...

The Waltham biotech signs more pharma deals than the average company, and already lists Vertex, Takeda and Biogen as its ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts ...

Columbia Threadneedle Investments reports Q2 results for its Large Cap Growth Fund, highlighting AI-driven gains and sector ...

New research on eltrombopag plus immunosuppressive therapy for severe aplastic anemia in young patients challenges the ...

In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo.

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs?

Vertex Pharmaceuticals is catching the eyes of bullish analysts, predicting a robust uptrend. Revenue trends and technical ...

Martin Mwita returned home to Bellevue this spring after becoming among the first in the country to receive one of two new gene therapies for sickle cell disease in St.

Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since ...

Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could top out at $2 ...